All studies
RecruitingNot ApplicableInterventional

A study of brain activity in visual snow syndrome and migraine

Visual snow syndrome is a condition where people see constant flickering static across their sight. Many people with visual snow also experience migraines, and there are currently no approved treatments. Researchers at King's College London and St Thomas' Hospital are running a study called FOCUS-VSM to understand how brain activity differs in people with visual snow and migraine. Using an advanced, ultra-high-detail MRI scanner, doctors will measure specific chemical messengers in the brain. Participants with visual snow or migraine will take either a medicine called lamotrigine or a dummy pill (placebo) for five weeks to see if it improves their symptoms. Healthy volunteers are also needed for a single scan to provide a comparison. The study lasts up to eight weeks, offers travel reimbursement, and hopes to uncover vital clues that could lead to new treatments in the future.

At a glance

Status
Recruiting
Phase
Not Applicable
Sponsor
King's College London
Enrolment target
75
Start
01 Sep 2026
Estimated completion
31 May 2028

What is this study about?

Visual snow syndrome is an unusual brain condition where people see continuous, tiny flickering dots over everything they look at, much like the static on an old television. People with this condition often experience other troubling visual symptoms as well, such as extreme sensitivity to bright light or seeing ghost-like 'afterimages' that linger after looking away. Because many people with visual snow also suffer from migraines, doctors believe these two conditions may share a similar root cause in the brain. At present, there are no proven or approved treatments available.

Scientists suspect that visual snow happens when the visual areas of the brain become overly active. This may be linked to an imbalance between two natural brain chemicals: glutamate, which excites brain cells, and GABA, which calms them down. To test this theory, researchers in London are using an ultra-powerful '7-Tesla' MRI scanner. This machine provides far clearer images than standard hospital scanners, allowing researchers to measure these brain chemicals directly.

In this trial, doctors want to see whether a medication called lamotrigine can help restore a healthy chemical balance. Lamotrigine is already used safely in the UK for other conditions to reduce glutamate levels. By comparing people who take the medication against those who take a dummy tablet (placebo), the team hopes to discover whether calming brain activity can reduce visual snow and migraine symptoms, paving the way for future therapies.

Key takeaways

  • Investigating the causes of visual snow syndrome and migraine using advanced 7T MRI scans.
  • Testing whether the medication lamotrigine can rebalance brain chemicals and ease symptoms.
  • Open to UK adults aged 18+ with visual snow, migraine, or healthy volunteers.
  • Requires visits to St Thomas' Hospital in London and taking tablets for five weeks (for patient groups).
  • Participants receive £50 per completed visit plus travel expenses up to £100.

Who may be eligible?

This study is open to adults aged 18 and over who can travel to London for hospital visits. The research team is looking for three different groups of people: adults diagnosed with visual snow syndrome (with or without migraine), adults who have migraines but do not have visual snow, and healthy volunteers who have neither condition to act as a comparison group.

To be eligible, you must be able to understand and sign consent forms in English, follow the study routine, and attend your appointments at St Thomas' Hospital. Women who can have children must agree to use an effective method of birth control during the medication period, as the trial drug is not suitable during pregnancy.

You may not be able to join if you have tried medications in the past that made your visual snow significantly worse, or if you have any medical reasons why an MRI scan or the trial medicine would not be safe for you.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am aged 18 or older.
  2. I have visual snow syndrome, migraine, or I am a healthy volunteer.
  3. I can travel to St Thomas' Hospital in London for brain scans.
  4. I can read, write, and understand English comfortably.
  5. If female and able to have children, I am willing to use reliable contraception during the trial.
Answer every question to see your result.

What does participation involve?

Taking part lasts up to eight weeks in total for people with visual snow or migraine, and one to two weeks for healthy volunteers. The trial begins with a telephone call to check if the study is right for you. If it is, you will visit St Thomas' Hospital in London for a detailed 7-Tesla MRI brain scan and fill out questionnaires about your symptoms.

Participants with visual snow or migraine are then randomly placed into one of two groups: one group takes lamotrigine tablets daily for five weeks, while the other takes dummy tablets (placebos). Neither you nor the study team will know which you are taking until the end. During these five weeks, you will log your symptoms in a quick electronic diary. After five weeks, you will return for a second MRI scan to see if brain activity has changed. You will then spend two weeks gradually lowering your dose to stop the medicine safely, followed by a final follow-up phone call. Healthy volunteers only take part in the initial scan and do not take any medication.

Potential risks and benefits

Taking part will not directly treat your condition, but the results could help doctors develop new therapies for visual snow in the future. To thank you for your time, you will receive £50 per hospital visit, plus up to £100 towards your travel costs. The MRI scans are very safe, though the powerful magnet can cause brief, harmless dizziness when sliding into the scanner. Lamotrigine can cause temporary side effects in some people, such as headaches, mild nausea, or a skin rash. The research team will watch over you carefully throughout the study. Taking part is entirely your choice, and you can leave the trial at any time without your regular NHS care being affected.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • Guy's and St Thomas' NHS Foundation Trust
    City only
    London, England

Common questions

Do I have to pay to take part in this study?

No, taking part is completely free. You will also receive £50 for each hospital visit and up to £100 to cover your travel expenses.

What is a placebo?

A placebo is a dummy tablet that looks identical to the real medicine but contains no active ingredients. It helps doctors see if changes are truly caused by the drug.

Is a 7-Tesla MRI scan safe?

Yes. It works just like a standard hospital MRI scanner but produces clearer pictures. Because the magnet is stronger, you might feel a brief wave of dizziness as you move into the machine.

Can I join if I do not have visual snow?

Yes. The researchers also need people who only have migraines, as well as healthy volunteers without visual snow or migraines, to act as comparison groups.

What happens if I change my mind during the study?

You are free to stop participating at any time. If you are taking the study medication, the doctors will simply advise you on how to reduce and stop the tablets safely.

How to find out more

Francesca Puledda

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "A study of brain activity in visual snow syndrome and migrai…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.